ASBP
NASDAQ · Pharmaceuticals
Aspire Biopharma Holdings In
$1.04
+0.24 (+29.51%)
Open$0.84
Previous Close$0.80
Day High$1.29
Day Low$0.83
52W High$35.01
52W Low$0.55
Volume—
Avg Volume213.4K
Market Cap3.30M
P/E Ratio—
EPS$-4.67
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.20M | 2.09M | 2.38M |
| Net Income | 266.8K | 312.0K | 325.1K |
| Profit Margin | 12.1% | 14.9% | 13.7% |
| EBITDA | 501.0K | 520.7K | 532.7K |
| Free Cash Flow | 197.3K | 259.9K | 336.6K |
| Rev Growth | +5.7% | +22.2% | +15.1% |
| Debt/Equity | 0.42 | 0.41 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |